1 / 28

Update on barcodes & medicines-associated issues in NHS

Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health judie.finesilver@cmu.nhs.uk 07785 573 914. Update on barcodes & medicines-associated issues in NHS. February 23 rd 2012 Franklin Room, IBM United Kingdom Limited, 76/78 Upper Ground,.

nimrod
Download Presentation

Update on barcodes & medicines-associated issues in NHS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health judie.finesilver@cmu.nhs.uk 07785 573 914 Update on barcodes & medicines-associated issues in NHS February 23rd 2012 Franklin Room, IBM United Kingdom Limited, 76/78 Upper Ground,

  2. What’s the current message ? • NHS dm+d • GS1 • EU Falsified Medicines Directive • Projects from CMU

  3. NHS Dictionary of Medicines and Devices – dm+d • Website • Name, strength, form of a medicine • No ambiguity • Enter the GTIN

  4. http://www.dmd.nhs.uk/

  5. No supply chain informaton.. No GTIN

  6. GTIN Global Trader Item Number GTIN- used to be known as EAN Managed by GS1- Global Standards 1 Population of GTIN field currently ~ 20% Working with BSA to appear in the browser

  7. Link between clinical and supply chain will support patient safety Example

  8. Similar looking product- very different clinical action

  9. Wrong label attached to product

  10. and it makes a noise

  11. What else could the barcode carry? Newer and cleverer carriers. QR code : 2D data matrix code Quick Response Code

  12. EU Falsified Medicines Directive http://www.manufacturingchemist.com/news/article_page/EC_consults_on_Falsified_Medicines_Directive/71100

  13. Safety Features? Tamper-Evident Seal Unique Identifier

  14. Process All POMs to be included and Medicines to be risk assessed for exclusion where the product is  a POM or for inclusion where the product is a prescription medicine. Risk assessments proposed to be based on cost, volume, risk to health.

  15. Issues • Cross industry issues: secondary care / homecare – who has responsibility for tracking and recording of codes? • Issues in primary care: connectivity and networking issues raised – verification response time needs to be short

  16. Discussion needed! • What are the most appropriate step(s) in the process for identification to happen ? – • Point of dispensing only • Point of dispensing plus random points along the supply chain • Point of dispensing plus systematically along the supply chain • Who is going to pay for this? • What happens if legislation changes? • Does this need enforcing – won’t happen otherwise?

  17. Pan European issues: • Europe are seeking harmonisation across Europe on standards, scanning mechanism (GS1 Or similar?) and repository approach • When importing, products will need to be checked out of one countries repository and into another • Who will hold the verification repository? options include: Centralised Europe repository, National Repository or a stakeholder owned repository (joint pharmacy and industry associations via not for profit organization). Complications include some countries may want to collaborate on setting up joint repositories and some may wish autonomy).

  18. Benefits • Patient safety –the most important • Efficiency improvements (though wholesalers voiced concerns over additional workload if scanning each pack was imposed) • Aid investigation of errors • Aid product recall process • Having a unique identifier will ensure counterfeiters can’t produce large batches of product – less cost effective • Companies that adopt 2D will be seen as having a differentiating factor when UK making purchasing decisions

  19. Risk manufacturers not willing to adopt will leave the UK market – what impact will that have on UK supply chain?

  20. Summary!

  21. Current Projects for CMU • KPI reports- • JAC v4.47 and Crystal X1 • Ascrbe v8 • Stockholding Report- • 2 email addresses • Homecare

  22. Homecare • Want to identify the homecare spend • Request to hospital pharmacy to include the word (Home) in the supplier names • And possibly to include the word (Home) in the product Description. • Onerous • Difficult • Are you affected?

  23. To Summarise • NHS dm+d- add product into Data base • GS1- not for profit global organisation- manage coding carriers • EU Falsified Medicines Directive- • tamper evidence and unique identification of product. • Risk assessment for opt-out for all POMs • for opt-in for all Ps • Projects for CMU- KPIs; Stockholding; • Homecare

  24. Judie Finesilver MRPharmS e-Business Pharmacist Commercial Medicines Unit, Department of Health judie.finesilver@cmu.nhs.uk 07785 573 914 Update on barcodes & medicines-associated issues in NHS February 23rd 2012 Franklin Room, IBM United Kingdom Limited, 76/78 Upper Ground,

More Related